肝炎患者-话题@MedSci

#肝炎患者#

130篇内容 | 3181人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1807879, encodeId=0e78180e87951, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Liver International：长期使用核苷类似物对慢性乙型肝炎患者脂肪因子与肝脂肪变性和纤维化的影响, objectType=article, longId=176258, objectId=f2141e6258a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2141e6258a4, replyNumber=0, likeNumber=122, createdTime=2020-03-22, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2141e6258a4, moduleTitle=Liver International：长期使用核苷类似物对慢性乙型肝炎患者脂肪因子与肝脂肪变性和纤维化的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2141e6258a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807872, encodeId=5f67180e87279, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=BMC Gastroenterology：接受直接作用抗病毒药物治疗的丙型肝炎患者的非侵袭性纤维化明显改善, objectType=article, longId=166010, objectId=40e31660102f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40e31660102f, replyNumber=0, likeNumber=58, createdTime=2019-06-24, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40e31660102f, moduleTitle=BMC Gastroenterology：接受直接作用抗病毒药物治疗的丙型肝炎患者的非侵袭性纤维化明显改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40e31660102f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807875, encodeId=4320180e87514, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=非一线核苷(酸)类似物经治慢性乙型肝炎患者治疗策略调整专家共识, objectType=article, longId=169063, objectId=44451690638b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44451690638b, replyNumber=0, likeNumber=31, createdTime=2020-01-20, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44451690638b, moduleTitle=非一线核苷(酸)类似物经治慢性乙型肝炎患者治疗策略调整专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44451690638b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807868, encodeId=93ad180e8681e, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=J Viral Hepatitis:转氨酶2倍以内慢性乙型肝炎患者抗病毒治疗决策的临床无创指标, objectType=article, longId=160677, objectId=8df71606e764, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8df71606e764, replyNumber=0, likeNumber=77, createdTime=2019-10-20, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8df71606e764, moduleTitle=J Viral Hepatitis:转氨酶2倍以内慢性乙型肝炎患者抗病毒治疗决策的临床无创指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8df71606e764)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807871, encodeId=f699180e87132, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Lancet：慢性丙型肝炎患者直接抗病毒治疗后的临床结局 ——前瞻性队列研究, objectType=article, longId=163130, objectId=4168163130f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4168163130f4, replyNumber=0, likeNumber=49, createdTime=2020-01-30, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4168163130f4, moduleTitle=Lancet：慢性丙型肝炎患者直接抗病毒治疗后的临床结局 ——前瞻性队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4168163130f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807859, encodeId=69c3180e85988, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=J Viral Hepat：丙型肝炎患者的神经精神症状与自身免疫性肝病患者相似但与乙型肝炎患者的神经精神状态不同, objectType=article, longId=147186, objectId=fa3914e18663, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa3914e18663, replyNumber=0, likeNumber=76, createdTime=2019-06-12, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa3914e18663, moduleTitle=J Viral Hepat：丙型肝炎患者的神经精神症状与自身免疫性肝病患者相似但与乙型肝炎患者的神经精神状态不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa3914e18663)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807866, encodeId=ad64180e866f5, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Clinical Gastro H：乙酰辅酶A羧化酶抑制剂GS-0976可减少非酒精性脂肪性肝炎患者肝脏的脂肪生成缺失和脂肪变性, objectType=article, longId=155519, objectId=635915551919, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=635915551919, replyNumber=0, likeNumber=70, createdTime=2019-01-03, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=635915551919, moduleTitle=Clinical Gastro H：乙酰辅酶A羧化酶抑制剂GS-0976可减少非酒精性脂肪性肝炎患者肝脏的脂肪生成缺失和脂肪变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=635915551919)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807870, encodeId=9095180e870c3, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=2019 共识指南：非酒精性脂肪性肝炎患者临床试验期间疑似急性药物性肝损伤的检测、评估和管理实践, objectType=article, longId=161354, objectId=39bc161354db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39bc161354db, replyNumber=0, likeNumber=29, createdTime=2019-06-09, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39bc161354db, moduleTitle=2019 共识指南：非酒精性脂肪性肝炎患者临床试验期间疑似急性药物性肝损伤的检测、评估和管理实践, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39bc161354db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807873, encodeId=c90d180e8737c, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=病毒性肝炎患者要会休息, objectType=article, longId=167551, objectId=4ad816e551e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ad816e551e4, replyNumber=0, likeNumber=136, createdTime=2019-09-29, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ad816e551e4, moduleTitle=病毒性肝炎患者要会休息, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ad816e551e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807865, encodeId=ecfd180e865f5, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=J Gastroenterology：Glecaprevir联合Pibrentasvir治疗对既往直接抗病毒治疗失败的慢性丙型肝炎患者的实际疗效分析, objectType=article, longId=151478, objectId=14541514e895, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14541514e895, replyNumber=0, likeNumber=63, createdTime=2019-09-19, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14541514e895, moduleTitle=J Gastroenterology：Glecaprevir联合Pibrentasvir治疗对既往直接抗病毒治疗失败的慢性丙型肝炎患者的实际疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14541514e895)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807858, encodeId=8299180e85898, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=J Viral Hepat：丙型肝炎患者使用三环抗抑郁药物后，纤维化进程延缓和肝硬化风险降低, objectType=article, longId=145322, objectId=e13d145322a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e13d145322a1, replyNumber=0, likeNumber=78, createdTime=2018-11-18, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e13d145322a1, moduleTitle=J Viral Hepat：丙型肝炎患者使用三环抗抑郁药物后，纤维化进程延缓和肝硬化风险降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e13d145322a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807855, encodeId=6145180e8556a, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=BMC Infect Dis：乙型肝炎和丙型肝炎患者死亡率趋势：以人口为基础的联系研究，1993-2012, objectType=article, longId=138863, objectId=e69e1388634c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e69e1388634c, replyNumber=0, likeNumber=90, createdTime=2019-02-08, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e69e1388634c, moduleTitle=BMC Infect Dis：乙型肝炎和丙型肝炎患者死亡率趋势：以人口为基础的联系研究，1993-2012, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e69e1388634c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807860, encodeId=0354180e860c7, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Gastroenterology：严重酒精性肝炎患者早期肝移植的结果分析, objectType=article, longId=147965, objectId=3bc414e9658e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bc414e9658e, replyNumber=0, likeNumber=77, createdTime=2018-09-22, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bc414e9658e, moduleTitle=Gastroenterology：严重酒精性肝炎患者早期肝移植的结果分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bc414e9658e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807861, encodeId=8a68180e8615c, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=J Hepatol：在抗病毒治疗期间，ALT水平正常与慢性乙型肝炎患者肝脏事件的风险降低有关, objectType=article, longId=149273, objectId=5fe91492e39e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fe91492e39e, replyNumber=0, likeNumber=69, createdTime=2019-05-02, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fe91492e39e, moduleTitle=J Hepatol：在抗病毒治疗期间，ALT水平正常与慢性乙型肝炎患者肝脏事件的风险降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fe91492e39e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807869, encodeId=3893180e86991, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=BMC Gastroenterology：超声可以用来评估慢性病毒性肝炎患者的肝硬度和颈动脉弹性, objectType=article, longId=160983, objectId=094c160983b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=094c160983b0, replyNumber=0, likeNumber=52, createdTime=2019-06-05, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=094c160983b0, moduleTitle=BMC Gastroenterology：超声可以用来评估慢性病毒性肝炎患者的肝硬度和颈动脉弹性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=094c160983b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807853, encodeId=e158180e85319, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Gastroenterology：皮质类固醇治疗可降低重度酒精性肝炎患者28天死亡率, objectType=article, longId=137537, objectId=b34e13e5378d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b34e13e5378d, replyNumber=0, likeNumber=72, createdTime=2018-12-04, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b34e13e5378d, moduleTitle=Gastroenterology：皮质类固醇治疗可降低重度酒精性肝炎患者28天死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b34e13e5378d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807847, encodeId=1d51180e84742, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Aliment Pharmacol Therap：亚洲慢性基因型1丙型肝炎患者适合跟干扰素说再见吗？, objectType=article, longId=131533, objectId=a440131533eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a440131533eb, replyNumber=0, likeNumber=72, createdTime=2018-03-14, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a440131533eb, moduleTitle=Aliment Pharmacol Therap：亚洲慢性基因型1丙型肝炎患者适合跟干扰素说再见吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a440131533eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807856, encodeId=ba4d180e8567d, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Hepatol Res：在韩国接受恩替卡韦/替诺福韦治疗的慢性乙型肝炎患者的肝细胞癌风险, objectType=article, longId=139531, objectId=82bb139531a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82bb139531a9, replyNumber=0, likeNumber=69, createdTime=2018-06-13, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82bb139531a9, moduleTitle=Hepatol Res：在韩国接受恩替卡韦/替诺福韦治疗的慢性乙型肝炎患者的肝细胞癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82bb139531a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807862, encodeId=7be1180e862ed, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Hepatology：在美国，慢性乙型肝炎患者的并发症和发病年龄, objectType=article, longId=149611, objectId=8d4d149611be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d4d149611be, replyNumber=0, likeNumber=64, createdTime=2019-04-04, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d4d149611be, moduleTitle=Hepatology：在美国，慢性乙型肝炎患者的并发症和发病年龄, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d4d149611be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807863, encodeId=e022180e86316, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=J Gastroenterology：高水平的血清Mac-2结合蛋白糖基化异构体（M2BPGi）可以预测用核苷酸类似物治疗的乙型肝炎患者肝细胞癌的发展, objectType=article, longId=150365, objectId=26e5150365cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26e5150365cc, replyNumber=0, likeNumber=60, createdTime=2019-04-26, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26e5150365cc, moduleTitle=J Gastroenterology：高水平的血清Mac-2结合蛋白糖基化异构体（M2BPGi）可以预测用核苷酸类似物治疗的乙型肝炎患者肝细胞癌的发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26e5150365cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肝炎患者

2020-05-29

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Liver International：长期使用核苷类似物对慢性乙型肝炎患者脂肪因子与肝脂肪变性和纤维化的影响

2020-03-22

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

BMC Gastroenterology：接受直接作用抗病毒药物治疗的丙型肝炎患者的非侵袭性纤维化明显改善

2019-06-24

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

非一线核苷(酸)类似物经治慢性乙型肝炎患者治疗策略调整专家共识

2020-01-20

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

J Viral Hepatitis:转氨酶2倍以内慢性乙型肝炎患者抗病毒治疗决策的临床无创指标

2019-10-20

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Lancet：慢性丙型肝炎患者直接抗病毒治疗后的临床结局 ——前瞻性队列研究

2020-01-30

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

J Viral Hepat：丙型肝炎患者的神经精神症状与自身免疫性肝病患者相似但与乙型肝炎患者的神经精神状态不同

2019-06-12

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Clinical Gastro H：乙酰辅酶A羧化酶抑制剂GS-0976可减少非酒精性脂肪性肝炎患者肝脏的脂肪生成缺失和脂肪变性

2019-01-03

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

2019 共识指南：非酒精性脂肪性肝炎患者临床试验期间疑似急性药物性肝损伤的检测、评估和管理实践

2019-06-09

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

病毒性肝炎患者要会休息

2019-09-29

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

J Gastroenterology：Glecaprevir联合Pibrentasvir治疗对既往直接抗病毒治疗失败的慢性丙型肝炎患者的实际疗效分析

2019-09-19

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

J Viral Hepat：丙型肝炎患者使用三环抗抑郁药物后，纤维化进程延缓和肝硬化风险降低

2018-11-18

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

BMC Infect Dis：乙型肝炎和丙型肝炎患者死亡率趋势：以人口为基础的联系研究，1993-2012

2019-02-08

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Gastroenterology：严重酒精性肝炎患者早期肝移植的结果分析

2018-09-22

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

J Hepatol：在抗病毒治疗期间，ALT水平正常与慢性乙型肝炎患者肝脏事件的风险降低有关

2019-05-02

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

BMC Gastroenterology：超声可以用来评估慢性病毒性肝炎患者的肝硬度和颈动脉弹性

2019-06-05

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Gastroenterology：皮质类固醇治疗可降低重度酒精性肝炎患者28天死亡率

2018-12-04

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Aliment Pharmacol Therap：亚洲慢性基因型1丙型肝炎患者适合跟干扰素说再见吗？

2018-03-14

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Hepatol Res：在韩国接受恩替卡韦/替诺福韦治疗的慢性乙型肝炎患者的肝细胞癌风险

2018-06-13

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Hepatology：在美国，慢性乙型肝炎患者的并发症和发病年龄

2019-04-04

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

J Gastroenterology：高水平的血清Mac-2结合蛋白糖基化异构体（M2BPGi）可以预测用核苷酸类似物治疗的乙型肝炎患者肝细胞癌的发展

2019-04-26

科室
- - 订阅+
  - 更多科室
工具
服务